Ticker Details
NewAmsterdam Pharma Company
IPO Date:	February 9, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.03B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.52 | 2.72%
Avg Daily Range (30 D):	$0.91 | 2.91%
Avg Daily Range (90 D):	$0.81 | 2.41%

Institutional Daily Volume
Avg Daily Volume:	.42M
Avg Daily Volume (30 D):	.79M
Avg Daily Volume (90 D):	.73M

Trade Size
Avg Trade Size (Sh.):	86
Avg Trade Size (Sh.) (30 D):	80
Avg Trade Size (Sh.) (90 D):	68

Institutional Trades
Total Institutional Trades:	1,160
Avg Institutional Trade:	$1.56M
Avg Institutional Trade (30 D):	$1.56M
Avg Institutional Trade (90 D):	$1.65M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.7M
Avg Closing Trade (30 D):	$2.32M
Avg Closing Trade (90 D):	$2.17M
Avg Closing Volume:	62.34K

News

Apr 2, 2026 @ 9:43 PM NewAmsterdam Pharma Reports Inducement Grants Unde... Source: Newamsterdam Pharma Company N.V.

Feb 4, 2026 @ 1:00 PM NewAmsterdam Pharma to Present at the Guggenheim E... Source: Newamsterdam Pharma Company N.V.

Aug 7, 2025 @ 12:21 AM NewAmsterdam (NAMS) Q2 Revenue Jumps 49% Source: Jesterai

Jun 9, 2025 @ 11:00 AM NewAmsterdam Pharma Announces Positive Topline Alz... Source: N/A

Jan 9, 2025 @ 8:38 PM NewAmsterdam Pharma Reports Inducement Grants Unde... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.72	$-.63	$-1.72
Diluted EPS	$-1.72	$-.63	$-1.72
Revenue	$22.5M	$.03M	$22.5M
Gross Profit
Net Income / Loss	$-203.82M	$-74.92M	$-203.82M
Operating Income / Loss	$-225.68M	$-65.98M	$-225.68M
Cost of Revenue
Net Cash Flow	$-293.18M	$-48.33M	$-293.18M
PE Ratio